Rafael A. Donassolo

Cp 354
Pelotas, RS 96160000, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Naturally acquired antibodies to Plasmodium vivax Pv_LISP-2, a potential liver stage vaccine antigen.

Naturally acquired antibodies to Plasmodium vivax Pv_LISP-2, a potential liver stage vaccine antigen.

Journal: Frontiers in immunology

Published: December 08, 2025

Toxoplasmosis infection and schizophrenia: Elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia.

Toxoplasmosis infection and schizophrenia: Elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia.

Journal: Schizophrenia research

Published: September 23, 2024

Exploring the naturally acquired response to Pvs47 gametocyte antigen.

Exploring the naturally acquired response to Pvs47 gametocyte antigen.

Journal: Frontiers in immunology

Published: June 26, 2024

Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model.

Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model.

Journal: Frontiers in immunology

Published: February 26, 2024

Immunogenicity of a pentavalent recombinant Escherichiacoli bacterin against enterotoxemia and botulism in sheep.

Immunogenicity of a pentavalent recombinant Escherichiacoli bacterin against enterotoxemia and botulism in sheep.

Journal: Anaerobe

Published: January 30, 2024

Evaluation of long-term immune response in cattle to botulism using a recombinant E. coli bacterin formulated with Montanide™ ISA 50 and aluminum hydroxide adjuvants.

Evaluation of long-term immune response in cattle to botulism using a recombinant E. coli bacterin formulated with Montanide™ ISA 50 and aluminum hydroxide adjuvants.

Journal: Microbial pathogenesis

Published: September 29, 2023

Recombinant Vaccine Design Against Clostridium spp. Toxins Using Immunoinformatics Tools.

Recombinant Vaccine Design Against Clostridium spp. Toxins Using Immunoinformatics Tools.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 17, 2021

Clostridium spp. Toxins: A Practical Guide for Expression and Characterization in Escherichia coli.

Clostridium spp. Toxins: A Practical Guide for Expression and Characterization in Escherichia coli.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 24, 2021

Recombinant Escherichia coli Cell Lysates as a Low-Cost Alternative for Vaccines Against Veterinary Clostridial Diseases.

Recombinant Escherichia coli Cell Lysates as a Low-Cost Alternative for Vaccines Against Veterinary Clostridial Diseases.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 24, 2021

Clostridium septicum: A review in the light of alpha-toxin and development of vaccines.

Clostridium septicum: A review in the light of alpha-toxin and development of vaccines.

Journal: Vaccine

Published: April 08, 2021

Evaluation of the expression and immunogenicity of four versions of recombinant Clostridium perfringens beta toxin designed by bioinformatics tools.

Evaluation of the expression and immunogenicity of four versions of recombinant Clostridium perfringens beta toxin designed by bioinformatics tools.

Journal: Anaerobe

Published: October 13, 2020

Formaldehyde effects on kanamycin resistance gene of inactivated recombinant Escherichia coli vaccines.

Formaldehyde effects on kanamycin resistance gene of inactivated recombinant Escherichia coli vaccines.

Journal: Biotechnology letters

Published: January 10, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026